Nazir, FH;
Camporesi, E;
Brinkmalm, G;
Lashley, T;
Toomey, CE;
Kvartsberg, H;
Zetterberg, H;
... Becker, B; + view all
(2021)
Molecular forms of neurogranin in cerebrospinal fluid.
Journal of Neurochemistry
10.1111/jnc.15252.
(In press).
Preview |
Text
Lashley_jnc.15252.pdf - Published Version Download (2MB) | Preview |
Abstract
Neurogranin (Ng) is a 78 amino acid neuronal protein and a biomarker candidate for Alzheimer’s disease (AD). Ng has been suggested to bind to calmodulin and phosphatidic acid via its centrally located IQ domain. Ng is cleaved within this functionally important domain, yielding the majority of fragments identified in cerebrospinal fluid (CSF), suggesting that cleavage of Ng may be a mechanism to regulate its function. Up to now, Ng has been shown to be present in CSF as both C‐terminal fragments as well as full‐length protein. To obtain an overview of the different molecular forms of Ng present in CSF, we show by size exclusion chromatography (SEC), immunoblotting, immunoprecipitation and MS that Ng is present in CSF as several molecular forms. Besides monomeric full‐length Ng, also higher molecular weight forms of Ng, and C‐terminal‐ and previously not identified N‐terminal fragments were observed. We found by immunodepletion that C‐terminal peptides contribute on average to ~50 % of the total‐Ng ELISA signal in CSF samples. There were no differences in the overall C‐terminal fragment/total‐Ng ratio between samples from AD and control groups. In addition, we found that monomeric Ng and its C‐terminal fragments bind to heparin via a heparin‐binding motif, which might be of relevance for their export mechanism from neurons. Taken together, this study highlights the presence of several molecular forms of Ng in CSF, comprising monomeric full‐length Ng, and N‐ and C‐terminal truncations of Ng, as well as larger forms of still unknown composition.
Archive Staff Only
 |
View Item |
